First-Line NSAID Therapy for Acute Pericarditis
Either aspirin (750-1000 mg every 8 hours) or ibuprofen (600 mg every 8 hours) should be used as first-line therapy for acute pericarditis, always combined with colchicine and gastroprotection. 111
Recommended NSAID Options
The 2015 ESC Guidelines provide Class I, Level A recommendations for aspirin or NSAIDs as first-line therapy 1. The two primary options are:
Aspirin
- Dosing: 750-1000 mg every 8 hours
- Duration: 1-2 weeks (symptom and CRP-guided)
- Tapering: Decrease by 250-500 mg every 1-2 weeks 11
Ibuprofen
- Dosing: 600 mg every 8 hours
- Duration: 1-2 weeks (symptom and CRP-guided)
- Tapering: Decrease by 200-400 mg every 1-2 weeks 11
How to Choose Between Aspirin and Ibuprofen
Choose aspirin when:
- Patient has coronary artery disease (CAD) requiring antiplatelet therapy 12
- Patient has heart failure 2
- Patient has renal disease 2
Choose ibuprofen when:
- No concomitant CAD, heart failure, or renal disease 12
- Patient is aspirin-naïve with asthma and nasal polyps 2
- Cost is a consideration (ibuprofen is more accessible and inexpensive) 2
Recent evidence from a 2024 Danish nationwide study of 12,381 patients demonstrated that ibuprofen use for acute pericarditis was not associated with increased cardiovascular risks (adjusted HR 0.69 for MACE), supporting its safety even at higher doses 3.
Critical Mandatory Co-Therapies
Colchicine (Class I, Level A recommendation)
Colchicine must be added to aspirin or ibuprofen therapy 11:
- Dosing: 0.5 mg once daily (<70 kg) or 0.5 mg twice daily (≥70 kg)
- Duration: 3 months for acute pericarditis
- Evidence: Colchicine halves the recurrence rate from 30% to 15% 1
Gastroprotection
Mandatory with all NSAID therapy to prevent gastrointestinal complications 11
Treatment Monitoring Algorithm
- Initiate therapy with chosen NSAID + colchicine + gastroprotection
- Monitor CRP to guide treatment duration and assess response 11
- Continue full dose until symptom resolution AND CRP normalization
- Begin tapering only after both symptoms resolve and CRP normalizes
- Taper one drug at a time - never taper multiple agents simultaneously 1
Critical Pitfalls to Avoid
Do NOT use corticosteroids as first-line therapy (Class III recommendation) 11. Corticosteroids increase recurrence rates up to 50% and promote drug dependence 11. Reserve corticosteroids only for:
- Contraindications to aspirin/NSAIDs (true allergy, recent GI bleeding, high bleeding risk on anticoagulation) 11
- Failure of aspirin/NSAIDs and colchicine 1
- Specific indications (autoimmune disease, pregnancy >20 weeks, post-pericardiotomy syndrome) 11
Inadequate initial treatment is a common cause of recurrence 11. Ensure full-dose therapy for adequate duration (1-2 weeks minimum) with proper tapering over 1-2 weeks per dose reduction 11.
Alternative NSAID Option
Indomethacin (25-50 mg every 8 hours) is a third option for recurrent pericarditis 11, but has higher CNS adverse effects (headache, dizziness) and requires starting at the lower end of dosing range with upward titration 1. It is not available over-the-counter in the USA 2.
Exercise Restriction
Restrict physical activity beyond ordinary sedentary life until symptom resolution AND CRP normalization 11: